| Announce Date | 10/16/2025 |
| EPS Normalized Actual | $1.28 (Beat by $0.15) |
| EPS GAAP Actual | $1.28 (Beat by $0.15) |
| Revenue Actual | $9.807B |
| Revenue Surprise | Beat by $9807M |
| Announce Date | 12/30/2025 (Pre-Market) |
| EPS Normalized Estimate | $1.12996 |
| EPS GAAP Estimate | $1.12996 |
| Revenue Estimate | $7.193110323B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.22 | 0.11847 | 9.807B | 72.47% | 2599.6M |
| FQ2 2025 (Jun 2025) | 1.11 | 0.04038 | 7.604B | -42.03% | 545.35M |
| FQ1 2025 (Mar 2025) | 1.03 | 0.05059 | 10.35B | -1.1% | 3441.48M |
| FQ4 2024 (Dec 2024) | 1.02 | 1.02 | 6.979B | 3.55% | 6979M |
| FQ3 2024 (Sep 2024) | 1.1 | 1.1 | 2.7B | -159.26% | 2700M |
| FQ2 2024 (Jun 2024) | 1.03 | 1.03 | 10.8B | 33.88% | 10800M |
| FQ1 2024 (Mar 2024) | 0.85 | 0.85 | 10.464B | 31.76% | 10464M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 6.731B | 5.87% | 6731M |
FQ4 Announce Date
12/30/2025 (Pre-Market)
Consensus EPS Estimates
1.12996
Consensus Revenue Estimates
7.193110323B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.39935 | -- | 1.39935 | 1.39935 | 1 |
| FQ3 2027 (Sep 2027) | 1.2798 | -- | 1.2798 | 1.2798 | 1 |
| FQ2 2027 (Jun 2027) | 1.2661 | -- | 1.2661 | 1.2661 | 1 |
| FQ1 2027 (Mar 2027) | 1.14785 | -- | 1.14785 | 1.14785 | 1 |
| FQ4 2026 (Dec 2026) | 1.288 | -- | 1.288 | 1.288 | 1 |
| FQ3 2026 (Sep 2026) | 1.24628 | 2.11 | 1.24628 | 1.24628 | 1 |
| FQ2 2026 (Jun 2026) | 1.20716 | 8.05 | 1.20716 | 1.20716 | 1 |
| FQ1 2026 (Mar 2026) | 1.05536 | 2.4 | 1.05536 | 1.05536 | 1 |
| FQ4 2025 (Dec 2025) | 1.12996 | 9.73 | 1.12996 | 1.12996 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 6.87B | -- | 6.87B | 6.87B | 1 |
| FQ3 2027 (Sep 2027) | 14.91B | -- | 14.91B | 14.91B | 1 |
| FQ2 2027 (Jun 2027) | 14.38B | -- | 14.38B | 14.38B | 1 |
| FQ1 2027 (Mar 2027) | 6.16B | -- | 6.16B | 6.16B | 1 |
| FQ4 2026 (Dec 2026) | 7.61B | -- | 7.61B | 7.61B | 1 |
| FQ3 2026 (Sep 2026) | 7.6B | -29.03 | 7.6B | 7.6B | 1 |
| FQ2 2026 (Jun 2026) | 7.46B | -1.9 | 7.46B | 7.46B | 1 |
| FQ1 2026 (Mar 2026) | 7.13B | -45.15 | 7.13B | 7.13B | 1 |
| FQ4 2025 (Dec 2025) | 7.19B | 2.98 | 7.19B | 7.19B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.10153 | 1.22 | 0.11847 | 9.71% |
| FQ2 2025 (Jun 2025) | 1.06962 | 1.11 | 0.04038 | 3.64% |
| FQ1 2025 (Mar 2025) | 0.97941 | 1.03 | 0.05059 | 4.91% |
| FQ4 2024 (Dec 2024) | 1.02 | 1.02 | 100% | |
| FQ3 2024 (Sep 2024) | 1.1 | 1.1 | 100% | |
| FQ2 2024 (Jun 2024) | 1.03 | 1.03 | 100% | |
| FQ1 2024 (Mar 2024) | 0.85 | 0.85 | 100% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $7.21B | $9.81B | $2599.6M | 26.51% |
| FQ2 2025 (Jun 2025) | $7.06B | $7.6B | $545.35M | 7.17% |
| FQ1 2025 (Mar 2025) | $6.91B | $10.35B | $3441.48M | 33.25% |
| FQ4 2024 (Dec 2024) | $0B | $6.98B | $6979M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.7B | $2700M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $10.8B | $10800M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $10.46B | $10464M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $6.73B | $6731M | 100% |